Alkem Lab Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2023	Dec-2022	Sep-2022	Jun-2022	Mar-2022
Gross Sales	2902.60	3040.91	3079.37	2576.38	2483.86
Excise Duty	--	--	--	--	--
Net Sales	2902.60	3040.91	3079.37	2576.38	2483.86
Other Operating Income	--	--	--	--	--
Other Income	68.67	45.33	50.67	51.41	20.52
Total Income	2971.27	3086.24	3130.04	2627.79	2504.38
Total Expenditure	2652.33	2441.86	2625.46	2373.14	2161.59
PBIDT	318.94	644.38	504.58	254.65	342.79
Interest	28.96	27.05	24.85	26.50	16.97
PBDT	289.98	617.33	479.73	228.15	325.82
Depreciation	78.32	78.44	77.40	76.26	83.14
Minority Interest Before NP	--	--	--	--	--
Tax	62.86	89.14	86.98	34.92	43.35
Deferred Tax	81.12	(10.21)	(32.37)	(14.48)	91.12
Reported Profit After Tax	67.68	459.96	347.72	131.45	108.21
Minority Interest After NP	(3.30)	5.25	16.88	3.81	0.63
Net Profit after Minority Interest	70.98	454.71	330.84	127.64	107.58
Extra-ordinary Items	(32.93)	--	--	--	(6.67)
Adjusted Profit After Extra-ordinary item	103.91	454.71	330.84	127.64	114.25
EPS (Unit Curr.)	5.94	38.03	27.67	10.68	9
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	2,000	--	--	1,500
Equity	23.91	23.91	23.91	23.91	23.91
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	10.99	21.19	16.39	9.88	13.80
PBDTM(%)	9.99	20.30	15.58	8.86	13.12
PATM(%)	2.33	15.13	11.29	5.10	4.36

QuickLinks for Alkem Laboratories Ltd.